Fundraising Fox
MarsBio
Venture capitalLos Angeles · 3 people tracked
Find your way into MarsBio
Sign up to see every warm intro you have to MarsBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MarsBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Fund manager profile
MarsBio is a venture fund manager based in Los Angeles. SEC filings show 1 venture fund on record, most recently MarsBio Fund I L.P. ($50M offering) filed March 2019.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
Team · 3 people
from public directories
What they invest in
from 2 of 2 portfolio companiesBiotech ×2AgTech ×1AI & Machine Learning ×1Deep Tech ×1Healthtech ×1
HQs:United States×2
Investments · 2 tracked
founders shown can be your intro path
Napigen is a biotechnology company developing genome editing technology targeting the mitochondrial and chloroplast genomes.
AgTechBiotechWilmington, US
Co-investorsRA CapitalThe Innovation SpaceGrantham Foundation
Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Robert DiFazio(Founder)inJuliana Hilliard(Founder)injennifer lee(Vice President of Finance \u0026 Operations)Christopher Riling(Vice President of Science)
Co-investorsAIX VenturesBreakout VenturesGaingelsHumba VenturesImmeasurableJulian Capital+19 more
__Twitter.png)
.jpeg){kind=logo}
Portfolio news
latest coverage across their companiesParallel Bio · finsmes.com · Jun 12, 2025
Frequently asked questions
- Where is MarsBio located?
- MarsBio is headquartered in Los Angeles, US.
Media · Podcasts & interviews
featuring the teamNetworking Corner with Arye Lipman, General Partner at MarsBio: “Commercialization of Science”
alumniucla · Arye Lipman
Co-investors · 1
VU Venture Partners is a global early-stage technology venture capital fund investing across the world's largest market opportunities, operating with a large investment team and six vertical-focused practices.
Firms observed investing alongside MarsBio, from public investor directories. Shared companies are the overlap with MarsBio's recorded portfolio.